Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2005-03-22
2005-03-22
LeGuyader, John L. (Department: 1635)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S006120, C435S091100, C435S455000, C536S023100, C536S024310, C536S024500
Reexamination Certificate
active
06869795
ABSTRACT:
A composition antisense oligomer directed to an mRNA preferentially expressed together with methods for treating stem cells with such a composition to increase the number of lineage committed progenitor cells and their progeny, and/or slow the growth of cancer cells. Also described is the use of such compositions and antisense oligonucleotide-treated stem cells in methods for treatment of cancer.
REFERENCES:
patent: WO 9321202 (1993-10-01), None
Srour, E.F. et al. J. of Hematotherapy, vol. 8: 93-102 (1999).*
Engel, B.C. et al. Frontiers in Bioscience, vol. 4: e26-33, May, 1999.*
Karen Pihl-Carey, Isis To Restructure As Crohn's Disease Drug Fails In Phase III, The Daily Biotechnology, vol. 10, No. 239, pp. 1-2.*
Andrea D. Branch, A good antisense molecule is hard to find, TIBS 23—Feb. 1998, pp. 45-50.*
Mitani K et al., Oncogenic potentials of the AML-1/EVI-1 fusion protein derived from the t (3; 21) (q26; q22) translocation in blastic crisis of chronic myelocytic leukemia, Journal Article.*
Giorgio Palu' et al., In pursuit of new developments for gene therapy of human diseases, Journal of Biotechnology 68 (1999) pp. 1-13.*
Stanley T. Crooke, Antisense Research and Application, pp. 1-50.*
Hendrikx, P.J., et al., Blood, 94: 682, (1999).
Mitani, K., et al., British Journal of Haematology, 90: 711-714, (1995).
Privitera, E., et al., Leukemia, 11: 2045-2048, (1997).
Shelly, L., et al., Journal of Cellular Biochemistry, 73: 164-175, (1999).
Summerton, J., et al., Antisense and Nucleic Acid Drug Development, 7: 187-195, (1997).
Tsai, S., et al., Bood, 96: 950-957, (2000).
Yagi, M., et al., Proc. Natl. Acsd. Sci. USA, 96: 8126-81, (1999).
International Search Report PCT/US 00/27636.
Ardhammar, M., et al., “In Vitro Membrane Penetration of Modified Peptide Nucleic Acid (PNA)”Journal of Biomolecular Structure&Dynamics 17(1):33-40 (1999).
Autuori, F., et al., “‘Tissue’ Transglutaminase and Apoptosis”Advances in Biochemical Engineering/Biotechnology 62: 129-136 (1998).
Brooks, D.J., et al., “Expression of the zinc finger gene EVI-1 in ovarian and other cancers”British Journal of Cancer 74:1518-1525 (1996).
Gray, G.E., et al., “Human Ligands of the Notch Receptor”American Journal of Pathology 154(3):785-794 (1999).
Gustincich, S., et al., “The HumanSerum Deprivation ResponseGene (SDPR) Maps to 2q32-q33 and Codes for a Phosphatidylserine-Binding Protein”Genomics 57:120-129 (1999).
Hayward, C.P.M., et al., “Multimerin Processing by Cells With and Without Pathways for Regulated Protein Secretion”Blood 94(4):1337-1347 (1999).
Larsen, H.J., et al., “Antisense properties of peptide nucleic acid”Biochimica et Biophysica Acta 1489pp. 159-166 (1999).
Sabo, S.L., et al., “Regulation of β-Amyloid Secretion by FE65, an Amyloid Protein Precursor-binding Protein”The Journal of Biological Shemistry 274(12):7952-7957 (1999).
Bartelmez Stephen H.
Iversen Patrick L.
AVI BioPharma Inc.
Gorthey Lee Ann
Judge Linda R.
LeGuyader John L.
Mahoney Jacqueline F.
LandOfFree
Antisense compositions and cancer-treatment methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense compositions and cancer-treatment methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense compositions and cancer-treatment methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3373114